| Literature DB >> 28703811 |
Bo Wu1, Jian Cui1, Xiang-Min Yang1, Zhen-Yu Liu1, Fei Song1, Ling Li1, Jian-Li Jiang1, Zhi-Nan Chen1.
Abstract
Hepatocellular carcinoma (HCC) is one of the most lethal and prevalentEntities:
Mesh:
Substances:
Year: 2017 PMID: 28703811 PMCID: PMC5550841 DOI: 10.1038/cddis.2017.251
Source DB: PubMed Journal: Cell Death Dis Impact factor: 8.469
Figure 1Low cholesterol inhibits CD147 endocytosis but triggers CD147 shedding. (a) Representative distribution of exogenous GFP-CD147 co-transfected with mCherry or ArfQ67L-mCherry in SMMC-7721 cells. Growing SMMC-7721 cells were transfected with GFP-CD147 and mCherry/ArfQ67L for 36 h. Exogenous GFP-CD147 was expressed on the membrane but accumulated when ArfQ67L was co-transfected. Treatment with MβCD (5 mM) 24 h after transfection significantly inhibited the formation of vacuoles. DAPI staining was used to visualize nuclei. Scale bar, 10 μm. Quantified results are shown as the mean±S.D. of three independent experiments. ***P<0.01. (b) Membrane CD147 levels in SMMC-7721 or HuH-7 cells were measured by FACS with anti-CD147-APC after treatment with various cholesterol-depletion materials. (c) Soluble CD147 (sCD147) levels in the corresponding culture supernatant of cholesterol-depleted cells were determined by ELISA. **P<0.01
Figure 2ADAM10 is responsible for CD147 shedding induced by cholesterol depletion. (a) Effects of GI254023X on the shedding of CD147. Growing SMMC-7721 or HuH-7 cells were pretreated with 10 μM GI254023X for 30 min before MβCD (5 mM) treatment for 4 h. Thereafter, the membrane CD147 of each group was measured by FACS, and sCD147 levels were measured by ELISA. *P<0.05, **P<0.01. (b) Knockdown of ADAM10 inhibits MβCD-dependent CD147 shedding in SMMC-7721 and HuH-7 cells. Growing SMMC-7721 or HuH-7 cells were first transfected with ADAM10 siRNA for 48 h, and then cells were treated with MβCD (5 mM) for 4 h to induce CD147 shedding. Thereafter, membrane CD147 and sCD147 levels were measured as described above. (c) Co-localization of CD147 and ADAM10 in SMMC-7721 and HuH-7 cells. The cells (5 × 105) were grown on coverslips for 24 h, fixed and stained with Dylight488-conjugated goat-anti-mouse antibodies (CD147, green) and Dylight594-conjugated goat-anti-rabbit antibodies (ADAM10, red; Pearson’s coefficients are indicated as numerical data to the right of each panel, n=3). Bar, 10 μm. (d) Co-IP analysis of CD147 and ADAM10. (e) HAb 18 blocks ADAM10/CD147 interaction. Resin was immobilized with 4 μg GFP antibody and then cell lysate mixture with/without HAb 18 was added to the resin to analyze ADAM10/CD147 interaction
Figure 3Residual CD147 was transported to lysosomes for further processing. (a) The degradation of CD147 follows two simultaneous degradation pathways. Growing SMMC-7721/CD147-GFP cells were first administered 2 μM MG132 or 20 μM chloroquine for 24 h and then assessed via western blot. (b) After inhibition of protein degradation with 2 μM MG132 or 20 μM chloroquine, cytoplasm localization of GFP was visualized via confocal microscopy. DAPI staining was used to visualize nuclei. Scale bar, 20 μm. (c) Immunofluorescence staining of CD147 (HAb 18: extracellular domain; c-19: intracellular domain) in SMMC-7721/CD147-GFP cells pretreated with 20 μM chloroquine (cells not treated as control). The transfected cells (5 × 105) were grown on coverslips for 24 h and treated with chloroquine (20 μM) for 12 h, and CD147 was then detected by immunofluorescence staining with HAb 18 or c-19, respectively. Bar, 20 μm. (d) Distribution of aggresomes induced by MG132 (as indicated by the arrowheads) and lysosomes visualized by CellLight Lysosomes-RFP, BacMam 2.0. Cycloheximide (100 μg/ml) pretreated for 12 h to inhibit protein synthesis in the lower panel. Scale bar: 20 μm. Quantified results are shown as the mean±S.D. of three independent experiments. ***P<0.001. (e) Distribution of scattered aggresomes induced by chloroquine (20 μM). Growing SMMC-7721/GFP-CD147 cells were pretreated with 5 μM MβCD for 4 h to inhibit protein internalization in the middle panel. Cycloheximide (100 μg/ml) was pretreated as described above in the lower panel. Scale bar, 20 μm. Quantified results are shown as the mean±S.D. of three independent experiments. **P<0.01
Figure 4Nuclear-localized CD147-ICD is related to autophagy of HCC cells. (a) Sequence alignment of the cytoplasmic tail of CD147 in different species. Identical sequences are highlighted in dark blue, strongly similar sequences in purple and weakly similar sequences in light green. The nuclear leading sequence (NLS) is marked above the sequence. (b–g) Different constructs were expressed in SMMC-7721 cells, and their locations were visualized via confocal microscopy. (b) dsRed2-C1; (c) dsRed2-C1-Hook1-S; (d) dsRed2-C1-CD147; (e) CD147-GFP+dsRed2-C1-CD147-ICD; (f) CD147-GFP+dsRed2-C1-CD147-ICD-△264-267; (g) GFP-C2-CD147-ICD. Scale bar, (b, c, e, f), 10 μm; (d and g), 20 μm. (h) Nuclear accumulation of CD147-ICD in SMMC-7721 cells transfected with GFP-C2-CD147-ICD. SMMC-7721 cells were first transfected with GFP-C2 or GFP-C2-CD147-ICD for 36 h, and then the cytoplasmic and nuclear extracts of the transfected cells were separated with NE-PER nuclear and cytoplasmic extraction reagents (78833, Thermo Scientific). Extracts were applied to western blot analysis, and lamin B was used as a loading control for the nuclear extracts. (i) HEK293 cells transfected with GFP-CD147-mCherry were first treated with chloroquine (20 μM) and then assessed via western blot. (j) Growing SMMC-7721/CD147-GFP cells were first starved by culturing in EBSS medium for 12 h or administered rapamycin (5 μM), chloroquine (20 μM) or 3-MA (10 mM) for 24 h and then assessed via western blot. (k) Immunofluorescence staining of LC3A/B. Scale bar, 10 μm. (l) Western blot analysis of LC3A/B in SMMC-7721 (N1/ICD) or HuH-7 (N1/ICD) cells
Figure 5The NF-κB–TRAIL–caspase8–Atg3 axis is involved in the CD147-ICD-promoted autophagy of HCC cells. (a) Luciferase assays were carried out in HEK293T cells to measure the effects of a GFP-tagged CD147-ICD (ICD) on the indicated reporters. **P<0.01. (b) The cluster heat map shows differentially expressed mRNAs in HuH-7 (GFP) and HuH-7 (CD147-ICD-GFP) cells (n=3). Gene expression levels were clustered based on log2 transformation. Red, green, or black represent up-, down-, or normally regulated expression levels, respectively. (c) Significant enriched pathway terms. (d) Inhibition of TNFSF10/TRAIL in CD147-ICD-overexpressed HuH-7 cells compared to control cells (Vehicle). (e) Downregulation of TRAIL mRNA in ICD-transfected SMMC-7721 or HuH-7 cells compared to control (Vehicle). **P<0.01. (f)Western blot was applied to analyze the effect of ICD on TRAIL and its downstream caspase8–ATG3 signaling. Western blot scanning densitometry for three independent experiments is shown on the right. Blots were probed for α-tubulin to ensure equal protein loading. *P<0.05, **P<0.01
Figure 6CD147-ICD confers chemoresistance to HCC cells by promoting autophagy. (a) SMMC-7721 (N1/ICD) or HuH-7 (N1/ICD) cells were treated with cisplatin (6 μg/ml) for 48 h. Cell viability was determined by MTT assays. Data are presented as the mean±S.E.M., n=3. (b) Inhibition of autophagy promotes cisplatin-induced cell death in SMMC-7721 (N1/ICD) cells. SMMC-7721 (N1/ICD) cells were transiently transfected with siRNA against beclin-1. The beclin-1 knockdown cells and the control-transfected cells were then treated with cisplatin for 48 h. SMMC-7721 (N1/ICD) cells were simultaneously treated with chloroquine (CQ) to inhibit autophagy and CQ-treated or control cells were then treated with cisplatin for 48 h. Cell viability was assessed by MTT assays. Data are presented as the mean±S.E.M., n=3. **P<0.01. (c) Inhibition of autophagy promotes cisplatin-induced cell death in HuH-7 (N1/ICD) cells. Huh-7 (N1/ICD) cells were treated as described above. ***P<0.001. (d) SMMC-7721 or HuH-7 cells were treated as indicated for 48 h. Cell viability was assayed by MTT assays. Data are presented as the mean±S.D., n=3. **P<0.01. ***P<0.001. (e) Tumor growth inhibition with HAb 18, cisplatin alone or combined in Balb/c nude mice bearing SMMC-7721 cell line xenografts. Treatment started 5 days after tumor cell inoculation and grew to approximately 100 mm3 in size. The mice were treated with intravenous injection of IgG or HAb 18 and/or cisplatin for two cycles of 10 d, n=4 tumors per treatment group. The mice were killed on day 25. Tumor size was measured by calipers. Tumor volume was calculated using the formula: (length × width2)/2. Data are presented as tumor volume (mm3) in the mean±S.D. (f and g) Primary tumors were harvested and weighed. Each group had four animals, and experiments were repeated twice. Data are expressed as the mean ±S.D. *P<0.05, **P<0.01
Figure 7General model for regulated intramembrane proteolysis of CD147 contributes to HCC progression. Under low-cholesterol conditions, constitutive shedding of CD147 mediated by ADAM10 is enhanced. Resulting circulating CD147 promotes malignant phenotypes in HCC cells. Residual CD147 after shedding still undergoes internalization and transports to lysosome for intramembrane proteolysis and releases the nuclear-localized CD147-ICD. Through NF-κB–TRAIL–caspase8–Atg3 axis, CD147-ICD promotes autophagy of HCC cells, the process which certainly benefits cancer cell survival under metabolic crisis (for example, chemotherapy)